Discovering 3 Undiscovered Gems in India for Potential Growth
In This Article:
Over the last 7 days, the Indian market has remained flat, yet it is up 45% over the past year with earnings expected to grow by 17% per annum over the next few years. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can lead to promising investment opportunities.
Top 10 Undiscovered Gems With Strong Fundamentals In India
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| Shree Digvijay Cement | 0.01% | 13.97% | 16.37% | ★★★★★★ |
| All E Technologies | NA | 40.78% | 31.63% | ★★★★★★ |
| Kokuyo Camlin | 27.11% | 23.20% | 75.70% | ★★★★★★ |
| Bharat Rasayan | 8.15% | 0.10% | -7.93% | ★★★★★★ |
| Aeroflex Industries | 0.04% | 14.69% | 33.38% | ★★★★★★ |
| TCPL Packaging | 95.84% | 15.51% | 31.89% | ★★★★★☆ |
| Indo Tech Transformers | 2.30% | 22.04% | 60.31% | ★★★★★☆ |
| Spright Agro | 0.58% | 83.13% | 86.22% | ★★★★★☆ |
| BLS E-Services | 1.67% | 15.04% | 51.58% | ★★★★★☆ |
| Innovana Thinklabs | 13.59% | 12.51% | 20.01% | ★★★★☆☆ |
Here we highlight a subset of our preferred stocks from the screener.
ASK Automotive
Simply Wall St Value Rating: ★★★★☆☆
Overview: ASK Automotive Limited, through its subsidiary, manufactures and sells auto components for the automobiles industry in India and has a market cap of ?92.44 billion.
Operations: ASK Automotive Limited generates revenue primarily from the manufacturing of auto components, amounting to ?32.00 billion. The company has a market cap of ?92.44 billion.
ASK Automotive has shown impressive growth, with earnings rising 44.8% last year, outpacing the Auto Components industry’s 20.1%. The company reported Q1 2024 sales of ?8.62 billion, up from ?6.57 billion a year ago, and net income of ?568 million compared to ?348 million previously. Despite a high net debt to equity ratio at 40.8%, interest payments are well covered by EBIT at 8.6x coverage, indicating strong financial health and quality earnings.
-
Click here to discover the nuances of ASK Automotive with our detailed analytical health report.
-
Review our historical performance report to gain insights into ASK Automotive's's past performance.
Marksans Pharma
Simply Wall St Value Rating: ★★★★★★
Overview: Marksans Pharma Limited, along with its subsidiaries, focuses on the research and development, manufacturing, marketing, and sale of generic pharmaceutical formulations globally and has a market cap of ?108.78 billion.
Operations: Marksans Pharma's revenue from the pharmaceutical segment stands at ?22.68 billion. The company has a market cap of ?108.78 billion.
Marksans Pharma, a promising player in the Indian pharmaceutical sector, has shown robust earnings growth of 21.7% over the past year, outpacing industry averages. The company’s debt to equity ratio improved from 19.9% to 11.7% in five years, indicating prudent financial management. Its net income for Q1 FY25 was INR 887.52 million, up from INR 686.58 million a year ago. Marksans is also exploring M&A opportunities to expand into Europe and recently received a positive inspection report from the USFDA for its Goa facility.